جست‌وجوی استاد و پژوهشگر

• Ion channels
• Electrophysiology
• Cardiac arrhythmia pharmacology
• +۳ مورد دیگر

Bo Hjorth Bentzen is an Associate Professor at the Department of Biomedical Sciences, University of Copenhagen, where he leads the Molecular Cardiology and Membrane Proteins research group. He is also a member of the Department Leadership team and represents The Faculty of Health and Medical Sciences in the UCPH Quantum HUB network. PhD in Health Sciences, University of Copenhagen (2010) M.Sc. in Human Biology, University of Copenhagen (2006) B.Sc. in Dentistry (2002) Pasteur Program in Leading and Managing Innovation, Harvard Business School (2015) Dr. Bentzen is a skilled ion channel electrophysiologist and pharmacologist with both academic and pharmaceutical training. His primary research focuses on diagnosing, understanding, and treating cardiac arrhythmia. He specializes in ion channels, electrophysiology, cardiac arrhythmia pharmacology, and novel ion channel targets for treatment of atrial fibrillation. His work combines drug discovery knowledge with cell, tissue, and animal experiments to understand heart physiology and develop novel diagnostic and therapeutic approaches for cardiac disorders. His recent publications show a strong focus on cardiac electrophysiology, particularly related to atrial fibrillation. His research examines potassium channels (KCa2, SK, KV7.1), sodium channels, and their roles in cardiac arrhythmias. Much of his work involves translational research, with several clinical trials investigating novel treatments for atrial fibrillation. His publication record also demonstrates interdisciplinary work connecting virology and cardiology, particularly in studying viral ion channels. Dr. Bentzen teaches dentistry, medical, medtech, and human biology students in cell biology, kidney physiology, and cardiac physiology and pharmacology. He serves as course leader for the Novo BRIDGE program "Translational tools I" and the PhD course in Innovation at SUND, UCPH. He supervises bachelor, master, and PhD students. His industry experience includes roles as a Consultant (Principal Scientist) at Acesion Pharma since 2017, and previously as Senior Scientist and Research Scientist at the same company. He directs research initiatives including the "Novel safe and effective pharmacological treatment for atrial fibrillation" project, a joint effort between University of Copenhagen and Acesion Pharma funded by Innovation Fund Denmark. He also serves on the steering committee of Arla Food for Health, a public-private research partnership.

Elaine Murrayمشاهده پروفایل

مدرس ارشد

• Mental Health
• Psychiatric Disorders
• Biomarker Research
• +۵ مورد دیگر

Dr. Elaine Murray is a Senior Lecturer in the School of Medicine at Ulster University, where she has been working since 2013. She is affiliated with the Northern Ireland Centre for Stratified Medicine and conducts research at the C-TRIC Building, Altnagelvin Area Hospital in Derry~Londonderry. Her work focuses on mental health research, particularly in college student populations, and she collaborates extensively with the Western Health and Social Care Trust and the Psychology Research Institute at Ulster University. Dr. Murray earned her BSc Hons in Biomedical Sciences with a Diploma in Industrial Studies from Ulster University in 2003. She completed her PhD in Neuroscience and Behaviour at the University of Massachusetts, Amherst in 2010, where her research demonstrated that perinatal disruption of histone acetylation leads to long-lasting changes in sexually dimorphic regions of the brain. Dr. Murray's research primarily focuses on identifying novel biomarker panels to improve diagnosis and treatment of psychiatric disorders. She is particularly interested in the role of epigenetic modifications and sex differences in the aetiology and treatment of mental health conditions. Her current projects include the Antipsychotic Response Study, Antidepressant Response research, Analysis of Antidepressant Prescribing Patterns in Northern Ireland, and the Ulster University Student Wellbeing Study, which is part of the WHO's Mental Health International College Student Project. Dr. Murray's extensive publication record shows a clear focus on mental health in college student populations, with particular attention to depression, suicidal behaviors, and the impact of childhood adversity. Her research employs multi-omics approaches to identify biomarkers and has increasingly incorporated microbiome analysis, particularly examining the relationship between oral microbiome variations and depression. She has established herself as a key contributor to the World Mental Health International College Student initiative, with numerous publications examining mental health patterns across international student populations. Vincent G. Dethier Award for Neuroscience and Behaviour Postgraduate Student of the year Fellow of the Higher Education Academy Member of the Society for Neuroscience Collaborative Award for Teaching Excellence (CATE) (2024) Distinguished Collaborative Education Excellence Fellowship (2023) Dr. Murray serves as coordinator of the Stratified Medicine Industrial Liaison Committee and as timetable coordinator for BSc (Hons) Stratified Medicine. She has secured significant research funding through projects like MOOD-Dx (as Principal Investigator), PEACETIME, iMPROVE, and the Personalised Medicine Centre Multi-Omics Lab. Her work with the Ulster University Student Wellbeing Study represents a major longitudinal research effort examining risk and protective factors for mental health problems in students over five years. Dr. Murray is actively involved in the Translational Neuroscience research group at Ulster University and collaborates with researchers across multiple disciplines. Her work on the Ulster University Student Wellbeing Study involves a large interdisciplinary team examining genetic and biological factors affecting mental health disorders and treatment efficacy. She also contributes to the Northern Ireland Centre for Stratified Medicine's efforts to develop personalized approaches to mental health treatment.

Katherine T. Millsمشاهده پروفایل

دانشیار

• Cardiovascular Disease Epidemiology
• Renal Disease Epidemiology
• Implementation Science
• +۵ مورد دیگر

Katherine T. Mills is an Associate Professor in the Epidemiology Department at Tulane University's School of Public Health and Tropical Medicine. Her research focuses on cardiovascular and renal disease epidemiology, implementation science, and health disparities, with particular emphasis on blood pressure control interventions and chronic kidney disease. Dr. Mills received her PhD in Epidemiology from Tulane University, completed a postdoctoral fellowship in cardiovascular disease epidemiology at Johns Hopkins University, earned an MSPH in Epidemiology from the University of North Carolina at Chapel Hill, and completed her undergraduate studies in Chemistry at Colorado College. Her research program spans multiple domains of public health and clinical epidemiology. Dr. Mills has established herself as a leader in studies examining the relationship between cardiovascular disease, kidney function, and health disparities. She has conducted extensive research on implementation science approaches to improve blood pressure control, particularly in underserved populations. Her work also investigates health outcomes in chronic kidney disease patients, including progression to end-stage renal disease, cardiovascular events, and mortality. Through her research, Dr. Mills has contributed significantly to understanding how social determinants of health impact cardiovascular outcomes and how community-based interventions can reduce health disparities. She has been particularly active in engaging Black churches as venues for cardiovascular health interventions. Analysis of Dr. Mills' recent publications reveals a strong focus on cardiovascular epidemiology, kidney disease outcomes, and implementation science for hypertension control. Her work frequently employs advanced statistical methods and large cohort studies, particularly the Chronic Renal Insufficiency Cohort (CRIC) study. She has published extensively on topics including blood pressure management, kidney disease progression, cardiovascular risk factors, and health disparities in minority populations. Her research often examines the intersection of social determinants of health with clinical outcomes. Dr. Mills has received numerous scientific awards including: 2020: Outstanding Achievement in Receiving Your First R01 Award 2018: Young Investigator Travel Award, NIH, NIGMS Seventh Biennial National IdeA Symposium of Biomedical Research Excellence (NISBRE) 2017: Sandra A. Daugherty Award for Excellence in Cardiovascular Disease for Hypertension Epidemiology, American Heart Association Council on Epidemiology and Prevention 2016: Award for Excellence in Research and Presentation by a Postdoctoral Fellow, Health Sciences Research Days, Tulane University 2015-2016: NIH/NHLBI T32 Cardiovascular Disease Epidemiology Training Program, Johns Hopkins University 2014: Dorothy R. LeBlanc Memorial Scholarship Award, Tulane University 2010-2012: Dean's Research Council Scholarship, Tulane University Dr. Mills has secured significant NIH funding for her research on blood pressure control interventions and health disparities. She has mentored numerous students and collaborated extensively with interdisciplinary teams across Tulane and other institutions. Her work on church-based interventions for cardiovascular health has been particularly influential in addressing racial health disparities. She has developed and tested multicomponent implementation strategies that engage community health workers and faith-based organizations to improve blood pressure control in low-income communities. Dr. Mills is actively engaged with the Chronic Renal Insufficiency Cohort (CRIC) study and has led multiple analyses examining cardiovascular outcomes in patients with chronic kidney disease. She collaborates with interdisciplinary teams including nephrologists, cardiologists, biostatisticians, and community health workers to address complex questions in cardiovascular and kidney disease epidemiology. Her current research focuses on identifying which populations benefit most from intensive blood pressure interventions and how social determinants of health influence treatment effectiveness.

• Tobacco Control
• Smoking Cessation
• Public Health
• +۵ مورد دیگر

Professor Billie Bonevski is a prominent health behaviour scientist currently serving as Professor at Flinders University, Adelaide, and Honorary Professor at the University of Newcastle's School of Medicine and Public Health. With over $30 million in research funding as Chief Investigator, including continuous NHMRC funding for the past decade, she has established herself as a leader in tobacco control research, particularly regarding disadvantaged populations. Her fields of interest include tobacco control, smoking cessation, public health, health promotion, cancer control, and addressing health inequities. According to bibliometric platforms, she ranks #2 in Australia for smoking cessation publications and #1 globally for smoking cessation and homelessness research, placing her in the top 0.1% of PubMed authors worldwide on tobacco smoking cessation. Professor Bonevski's research portfolio demonstrates a strong focus on translating evidence into practice, with her work influencing policies such as routine distress screening in oncology centers and the implementation of the Cancer Council's Tackling Tobacco Program across multiple Australian states. Her publication record includes 198 peer-reviewed papers, 71% in top quartile journals, with significant international collaboration. 2018 APSAD Mentor Award 2016 Thoracic Society of Australia and New Zealand's President's Prize for tobacco control 2019 Research Impact Award for RADICALS Project 2011 Publication Award 'Highest Publication Rate' As an active research leader, Professor Bonevski serves on the international Society for Research in Nicotine & Tobacco board, previously as founding President of the SRNT Oceania Chapter. She has received continuous funding through prestigious fellowships including NHMRC Career Development Fellowships and Cancer Institute NSW Career Development Fellowships, supporting her translational research program that bridges academic scholarship with real-world health outcomes. Her laboratory work focuses on implementing smoking cessation interventions across diverse settings including drug and alcohol treatment services, mental health facilities, and community social services, with particular attention to reaching socioeconomically disadvantaged populations. Current projects include investigating vaporized nicotine products for smoking cessation among priority populations and embedding smoking cessation support within lung cancer screening programs.

• Healthcare Leadership
• Person-Centered Care
• Empowerment in Healthcare
• +۵ مورد دیگر

Annette Nygård serves as Associate Professor of Nursing and Assistant Professor of Leadership and Organization in Healthcare at the University of Borås within the Academy of Care, Working Life and Welfare and Department of Working Life and Welfare. As a registered nurse with specialist anesthesia training and extensive academic leadership experience, she bridges clinical practice with scholarly work to advance healthcare systems. Her educational foundation includes specialized anesthesia training and doctoral research culminating in the 2013 dissertation A quality improvement project on empowerment in chronic kidney care: an interactive research approach . This work established her commitment to patient-centered methodologies through interactive research designs that strengthen empowerment of patients and families. Dr. Nygård's research program targets clinically relevant quality improvements across individual and structural levels, with core concepts including empowerment, person-centered care, self-care, and e-health. Her work actively investigates healthcare policy implementation across organizational tiers while developing practical frameworks for sustainable care transformation through improvement knowledge and leadership education. She supervises doctoral researchers including Johanna Falck from Jönköping University's School of Health, extending her mentorship beyond institutional boundaries to cultivate next-generation healthcare scholars focused on patient-centered innovation.

Natalie Manginsayمشاهده پروفایل

دانشیار بالینی

• Avian Mycoplasmosis
• Poultry Disease Diagnostics
• Poultry Disease Investigations
• +۲ مورد دیگر

Dr. Natalie Manginsay is an Associate Clinical Professor of Avian Medicine at Mississippi State University's College of Veterinary Medicine, affiliated with the Department of Pathobiology & Population Medicine. She supervises the Poultry Serology and AGID sections at the Poultry Research & Diagnostic Laboratory, providing diagnostic support to Mississippi's poultry industry. Education: Ph.D. in Veterinary and Biomedical Sciences, University of Georgia (2014) Master of Avian Medicine, University of Georgia (2010) BVSc in Veterinary Science, University of Pretoria, South Africa (2004) Research Focus: Dr. Manginsay specializes in avian mycoplasmosis, poultry disease diagnostics, and epidemiological investigations. Her work emphasizes improving disease detection methods and developing practical solutions for poultry health management, with field-based research on pathogens like Mycoplasma gallisepticum , Clostridium, and avian reoviruses. Publications: Her recent works (2020–2023) predominantly address emerging challenges in poultry health, including novel disease presentations, vaccine efficacy, and wild turkey mortality. Common themes include diagnostic innovations, pathogen surveillance, and industry-focused disease mitigation strategies. Honors: Diplomate, American College of Poultry Veterinarians Professional Activities: She actively trains veterinary/graduate students through field trips and classroom instruction, contributes to the Veterinary and Biomedical Science Master’s program, and presents regularly at conferences (e.g., AAAP, AAVLD). She also develops workshops on mycoplasma diagnostics for the National Poultry Improvement Plan.

Abdu Ademمشاهده پروفایل

استاد

• Neuroscience
• Pharmacology
• Diabetes Research
• +۳ مورد دیگر

Prof. Abdu Adem is a Professor at the College of Medicine , Khalifa University , Abu Dhabi, with a career spanning over three decades. He previously served as a full Professor at the College of Medicine and Health Sciences, United Arab Emirates University (UAEU) from 1991 to 2020. Education : Ph.D. in Pharmacology (1987) from Uppsala University, Sweden; Docent title (Habilitation) from Karolinska Institute, Sweden (1991). Research Interests focus on neurodegeneration , particularly Alzheimer's disease, and diabetes biology , addressing its complications in the UAE population (24-28% prevalence). His work bridges neuroscience , pharmacology , and drug development . Article Trends highlight his expertise in anti-diabetic compounds (steroidal lactones, cycloheptylamine derivatives), neuroprotection (myrcene, valeric acid), and desert adaptation (camel physiology). Recent studies explore PPARγ activation , GLP-1 receptor agonists , and AGEs in diabetic complications . Scientific Awards : Sheikh Hamdan Award for Medical Sciences Nominated for Mohamed Bin Rashid Medal of Scientific Distinguishment Golden visa (10 years) by UAE Prime Minister Member of Mohamed Bin Rashid Academy of Scientists (MBRAS) Grants : Secured funding from European Union, Michael J. Fox Foundation, Sheikh Hamdan Bin Rashid Grant, UAEU, and Khalifa University. Labs/Teams : Leads research teams investigating neurodegeneration , diabetic complications , and camel physiology .

Soraia De Camargo Catapanمشاهده پروفایل

مدرس

• Telehealth
• Digital Health
• Health Services Research
• +۶ مورد دیگر

Dr. Soraia De Camargo Catapan is a Research Fellow and Lecturer at the Centre for Health Services Research within the Faculty of Health, Medicine and Behavioural Sciences at The University of Queensland. She is also an affiliate of the Centre for Online Health. With international experience spanning Brazil, the UK, and Australia, she holds a PhD in Public Health and specializes in telehealth implementation, digital health trust, and chronic disease management. Her research focuses on: Telehealth and digital health adoption Trust and confidence measurement in digital healthcare Co-design and participatory approaches for chronic conditions Health services research and implementation science Cross-cultural telehealth applications She employs mixed-methods, cross-sectional studies, and systematic reviews to evaluate digital health interventions. Her recent publications (2023-2025) demonstrate strong thematic consistency in telehealth optimization, instrument development for trust measurement, and chronic disease management innovations. Over 60% of her 23+ publications appear in Q1 journals, with international collaborations across 4+ countries. Awards & Recognition: CAPES-BR Best PhD Thesis Award Dual Best Scientific Paper Awards at 2023 Success and Failures of Telehealth Conference National Heart Foundation of Australia grant recipient (2022-2023) Academic Contributions: Supervises PhD candidates in digital health education and cancer care innovation. Leads the UQ-COH Telehealth Consumer Reference Group and an international research partnership between Australia and Brazil. Has taught 7+ courses to 580+ students since 2023.

Ken Inokiمشاهده پروفایل

دانشیار

• mTOR signaling pathway
• Cellular growth regulation
• Signal transduction
• +۴ مورد دیگر

Ken Inoki is the Roger C. Wiggins Collegiate Professor of the Life Sciences and a Research Associate Professor at the University of Michigan Life Sciences Institute. He holds Associate Professor appointments in both the Division of Nephrology, Department of Internal Medicine and the Department of Molecular & Integrative Physiology at the U-M Medical School. His research focuses on the mechanistic target of rapamycin (mTOR) signaling pathway’s role in diabetes, aging, and cancer. Education : MD (1991) and PhD (1998) in Biochemistry & Molecular Biology from Shiga University of Medical Science, Japan Clinical background : 8 years as a physician in Nephrology at University Hospital, Japan Key affiliations : U-M Life Sciences Institute, Medical School, and Klatskin-Sutker Discovery Fund recipient Research Interests : Dr. Inoki investigates how the mTOR pathway coordinates nutrient and growth factor signals to regulate protein synthesis, lipid biogenesis, and cellular proliferation. His work bridges basic science and clinical applications , addressing pathologies in diabetic nephropathy, cancer, and age-related disorders through biochemical and genetic approaches . Scientific Awards : Koikai Award for Excellence in Basic Science (2004) Biological Sciences Scholar, University of Michigan (2008) Lab Members : Collaborates with multi-disciplinary teams at the Ken Inoki Lab (Room 6183A, Life Sciences Institute) on projects funded by the Klatskin-Sutker Discovery Fund, focusing on antiparasitic development and kidney disorder prevention .

• Cardiovascular Medicine
• Pharmacology
• Vascular Biology
• +۵ مورد دیگر

Kathleen Martin is a Professor of Medicine (Cardiovascular Medicine) and Pharmacology at Yale School of Medicine, where she also serves as Co-Director of the Yale Cardiovascular Research Center (YCVRC). Her academic journey began at Hiram College where she earned her BA in Biology (1990), followed by a PhD in Physiology and Biophysics from Case Western Reserve University (1997), and postdoctoral training at Harvard Medical School (1998-2000). BA in Biology, Hiram College (1990) PhD in Physiology and Biophysics, Case Western Reserve University (1997) Postdoctoral Fellowship, Harvard Medical School (1998-2000) Dr. Martin's research focuses on the molecular mechanisms regulating vascular smooth muscle cell (SMC) phenotypic plasticity, with particular emphasis on epigenetic regulation through enzymes like TET2. Her work explores how SMCs maintain the ability to de-differentiate and re-enter the cell cycle, which is essential for angiogenesis but also contributes to atherosclerosis, intimal hyperplasia, and restenosis. She investigates the mTOR pathway's role in SMC differentiation and how rapamycin affects vascular disease processes, aiming to develop novel therapeutics that avoid the adverse effects of systemic rapamycin treatment. Analysis of Dr. Martin's most recent publications reveals a strong focus on vascular remodeling mechanisms, with particular attention to epigenetic regulation of SMC phenotype, TET2-mediated chromatin remodeling, and the intersection of vascular biology with immunology and developmental processes. Her work spans from basic molecular mechanisms to translational applications in vascular disease treatment. Alexander W. Clowes Distinguished Lecturer (2022) Dr. Martin has held significant leadership roles including Chair of the AHA Vascular Discovery Meeting Planning Committee and service on the Yale IACUC. She collaborates extensively with researchers across Yale and beyond, particularly with John Hwa, Alan Dardik, and Daniel Greif. Her lab participates in multiple institutional programs including the Vascular Biology and Therapeutics Program, Yale Combined Program in the Biological and Biomedical Sciences, and the Yale Stem Cell Center. The Martin Lab, located within the Department of Cardiovascular Medicine, focuses on understanding how regulation of the muscular layer of blood vessels contributes to normal vessel function and cardiovascular disease. The lab investigates key areas including vascular smooth muscle differentiation, signal transduction, transcription, and epigenetics using disease models of atherosclerosis, intimal hyperplasia, transplant vasculopathy, obesity, and diabetes.

Erin Gallagherمشاهده پروفایل

دانشیار

• Palliative Care
• Family Medicine
• Advance Care Planning
• +۵ مورد دیگر

Erin Gallagher is an Associate Professor in the Department of Family Medicine at McMaster University . Her work focuses on the intersection of palliative care, chronic disease management, and advance care planning within primary care settings. Research Themes: Advance care planning, end-of-life care, chronic disease management, health services research, and medical education. Key Collaborations: Canadian Family Physician, Royal Australian and New Zealand College of Psychiatrists, and interdisciplinary teams in palliative care and urban health. Recent publications highlight her contributions to understanding care patterns in heart failure, COPD, and kidney failure patients. Gallagher also explores strategies for antipsychotic-associated weight gain and leadership training in medical education. Her scholarly activity emphasizes improving patient experiences through quality initiatives like the Serious Illness Care Program . Gallagher’s work extends to urban health, particularly evaluating child-friendly spaces and city planning impacts on public health.

• Nephrology
• Biomineralization
• Health Informatics
• +۳ مورد دیگر

Jessica Saw serves as a Teaching Professor at the Carle Illinois College of Medicine, University of Illinois Urbana-Champaign, where she directs the Renal program within Biomedical and Translational Sciences. Her instructional responsibilities include teaching Renal (BSE 633) and Human Anatomy & Physiology Laboratory courses (MCB 245/247), emphasizing hands-on medical education for future physicians. Her research spans nephrology, biomineralization, and health informatics, with dual focus on kidney stone pathophysiology and health data communication. She investigates microbial entombment in urolithiasis, in vivo stone dissolution mechanisms, and develops visual hierarchies for health data. Additional interests include bedside art interventions for oncology patients and translational studies in diabetic gastroparesis, reflecting her commitment to patient-centered innovation. Publication analysis reveals three dominant research trajectories: (1) Geobiological studies of kidney stones (2018-2021) demonstrating microbial roles in biomineralization, (2) Health informatics work (2023-2024) addressing infodemics and data visualization, and (3) Clinical interventions (2014-2018) exploring pharmacological pathways and non-pharmacological therapies. Her work consistently bridges basic science with clinical applications in renal health and patient experience optimization.

Aron Lukacherمشاهده پروفایل

استاد

• Polyomavirus Infections
• T Cell Immunity
• Virology
• +۳ مورد دیگر

Aron Lukacher is a Professor in the Department of Cell and Biological Systems and Department of Pathology and Laboratory Medicine at Penn State University. He holds affiliations with the Penn State Clinical and Translational Science Institute (CTSI), Penn State Cancer Institute, and One Health Microbiome Center, focusing on polyomavirus pathogenesis and immune responses. Research Focus: Polyomavirus infections, T cell immunity, immune evasion mechanisms, and organ-specific viral pathogenesis in the central nervous system and kidneys. Grants: Multiple NIH-funded projects including those from the National Institute of Neurological Disorders and Stroke and National Institute of Allergy and Infectious Diseases spanning 2012-2026. His recent work explores chemokine receptor interactions (e.g., CXCR4/CXCR6) in neuroinflammation, viral persistence in kidneys, and antiviral drug development (e.g., Brincidofovir). Articles highlight both basic virology and translational applications in clinical science. Labs/Teams: Collaborations with the Penn State Cancer Institute's Mechanisms of Carcinogenesis program and One Health Microbiome Center.

Sarah Dameryمشاهده پروفایل

پژوهشگر ارشد

• Health Services Research
• Chronic Disease Management
• Mixed Methods Research
• +۳ مورد دیگر

Dr Sarah Damery is a Research Fellow at the University of Birmingham's Department of Applied Health Sciences within the College of Medicine and Health, a position she has held since September 2008. Her work focuses on evaluating health and social care service delivery for chronic conditions through the West Midlands Applied Research Collaboration (ARC), where she leads Theme 1 initiatives. Previously, she contributed to cancer research and chronic disease projects within the West Midlands CLAHRC from 2014-2019. Educational background: PhD in Geography, University of Cambridge, 2006 MA in Geography, University of Cambridge, 2002 BA(Hons) in Geography, University of Cambridge, 1999 Her research integrates mixed-methods approaches across diverse health domains including nephrology, cardiology, and sexual violence support services. Key interests encompass early diagnosis of chronic diseases, implementation of integrated care models, and organizational factors influencing service delivery. She specializes in combining quantitative analysis with qualitative insights to assess patient outcomes and service effectiveness, particularly in home-based care settings and voluntary sector collaborations. Analysis of her 15 most recent publications reveals dominant themes in chronic disease management, with significant contributions to dialysis services research (examining organizational culture and geographical variation), technology-enabled cardiac rehabilitation, and sexual violence support systems. Her work consistently employs mixed-methods designs across nephrology, respiratory medicine, and public health domains, with growing emphasis on LGBT health education and voluntary sector service commissioning. A notable trend involves evaluating systemic changes in healthcare delivery through multidisciplinary partnerships. Dr Damery actively collaborates on major grant-funded initiatives including the West Midlands ARC and PROSPER study, though specific grant details and student supervision records aren't publicly documented. Her work demonstrates consistent leadership in large-scale applied health research projects involving NHS partnerships and voluntary sector organizations. She currently contributes to Theme 1 of the West Midlands ARC, focusing on integrated care for chronic conditions, and collaborates extensively with sexual violence support services through the PROSPER co-production study. Her research methodology emphasizes real-world implementation within complex healthcare systems through multidisciplinary teams spanning clinical, academic, and community sectors.

• Immunology
• Pharmacology
• Inflammation Biology
• +۵ مورد دیگر

Dr. Saskia Overbeek is a Researcher in the Department of Pharmacology within the Faculty of Science at Utrecht University. Her research spans immunology, pharmacology, and nutritional science with a focus on how dietary components modulate immune responses and inflammation. Dr. Overbeek's research interests include: Immune regulation through dietary components Human milk oligosaccharides and immune development Neutrophil biology in inflammatory conditions Gut-lung axis and mucosal immunity Microbiome-immune system interactions Development of nutritional interventions for immune-related disorders Her publication record (2007-2024) demonstrates an evolution from neutrophil biology in respiratory diseases to broader investigations of dietary immunomodulation. Recent work (2018-2024) focuses on how human milk oligosaccharides and other prebiotics influence immune responses, particularly their ability to suppress Th2 responses while enhancing Th1 and regulatory pathways. This research has implications for allergy prevention, vaccine efficacy, and inflammatory conditions. Key scientific contributions: Extensive publication record in high-impact journals including Nature Reviews Nephrology, PLoS One, and Gut Pioneering work on N-acetyl proline-glycine-proline and neutrophil-mediated inflammation Significant contributions to understanding gut-kidney axis in chronic kidney disease Research on how dietary components modulate immune responses in vaccination and allergy contexts Dr. Overbeek has maintained extensive collaborations with researchers at Utrecht University, particularly with colleagues in pharmacology, immunology, and nutritional sciences. Her work typically employs in vitro models using intestinal epithelial cells and immune cells, complemented by murine models to study immune responses in vivo.